Oppenheimer Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-9,561
| Closed | -$1.49M | – | 1223 |
|
|
2020
Q4 | $1.49M | Buy |
9,561
+421
| +5% | +$65.8K | 0.02% | 561 |
|
|
2020
Q3 | $1.05M | Buy |
9,140
+743
| +9% | +$85K | 0.02% | 603 |
|
|
2020
Q2 | $942K | Buy |
8,397
+931
| +12% | +$104K | 0.02% | 612 |
|
|
2020
Q1 | $670K | Buy |
7,466
+1,051
| +16% | +$94.3K | 0.02% | 661 |
|
|
2019
Q4 | $694K | Buy |
6,415
+797
| +14% | +$86.2K | 0.01% | 721 |
|
|
2019
Q3 | $550K | Sell |
5,618
-2,149
| -28% | -$210K | 0.01% | 783 |
|
|
2019
Q2 | $1.02M | Sell |
7,767
-520
| -6% | -$68.1K | 0.02% | 616 |
|
|
2019
Q1 | $1.12M | Sell |
8,287
-15,023
| -64% | -$2.03M | 0.03% | 582 |
|
|
2018
Q4 | $2.27M | Sell |
23,310
-1,850
| -7% | -$180K | 0.06% | 341 |
|
|
2018
Q3 | $3.5M | Buy |
25,160
+1,220
| +5% | +$170K | 0.08% | 294 |
|
|
2018
Q2 | $2.97M | Buy |
23,940
+705
| +3% | +$87.5K | 0.07% | 308 |
|
|
2018
Q1 | $2.59M | Buy |
23,235
+1,035
| +5% | +$115K | 0.07% | 322 |
|
|
2017
Q4 | $3.11M | Hold |
22,200
| – | – | 0.08% | 283 |
|
|
2017
Q3 | $3.11M | Buy |
22,200
+965
| +5% | +$135K | 0.08% | 285 |
|
|
2017
Q2 | $2.58M | Sell |
21,235
-1,326
| -6% | -$161K | 0.07% | 300 |
|
|
2017
Q1 | $2.74M | Buy |
+22,561
| New | +$2.74M | 0.08% | 284 |
|